Drug intelligence / Profile preview

Avishield ND

Development stage: Unknown
Lead developer: Dechra
Modality: Vaccines & Immunotherapeutics
Administration: Oculonasal, Drinking Water, Coarse Spray

Overview

Avishield ND is a live, attenuated veterinary vaccine developed for the active immunization of chickens and turkeys against Newcastle disease virus (NDV). It contains either the Hitchner B1 strain or La Sota strain of the lentogenic Newcastle disease virus. The vaccine works by inducing active immunity through the controlled replication of the attenuated virus within the vaccinated birds, thereby reducing mortality and clinical signs associated with Newcastle disease.

Brand names: Avishield NDAvishield ND B1

Beyond the preview

Go deeper on Avishield ND.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avishield ND.

Explore the full profile